Quagen`s Generic Butalbital, Acetaminophen and Caffeine Receives Approval in the U.S.
Hikma Pharmaceuticals's Generic Dabigatran Etexilate Mesylate Receives Approval in the U.S.
WALL, S.D. and ATLANTA, March 17, 2022 /PRNewswire/ -- Seton Pharmaceuticals, LLC and Senores Pharmaceuticals, Inc. today announced the launch of Butalbital, Acetaminophen and Caffeine Capsules USP, 50 mg/325 mg/40 mg, a therapeutic equivalent of the reference listed drug Butalbital, Acetaminophen, and Caffeine capsules of Mayne Pharma, Inc. in the U.S. market. The product will be distributed by Seton Pharmaceuticals, LLC.
Aurobindo's Generic Acetaminophen, Aspirin & Caffeine Receives Approval in U.S.
Hikma's Generic Butalbital, Acetaminophen, Caffeine Receives Approval in U.S.
RiconPharma's Generic Butalbital, Acetaminophen & Caffeine Receives Approval in the US
LGM Pharma's Generic Aspirin ;Butalbital Caffeine; Receives Approval in US
Strides Pharma's Generic Acetaminophen:Butalbital: Caffeine Receives Approval In US
Nesher Pharms` Generic Acetaminophen;Butalbital;Caffeine Receives Approval In US
Strides Pharma`s Generic Acetaminophen;Codeine Phosphate;Butalbital;Caffeine Receives Approval in U.S